MYGN
Myriad Genetics, Inc.
Myriad Genetics is a molecular diagnostics company with minimal political/regulatory footprint and low government revenue dependence.
Next filing → your inbox
Govt Dependence
25/100
Regulatory Density
45/100
Lobbying Intensity
15/100
Political Signal
LOW
BusinessWhat MYGN does
Myriad Genetics develops and commercializes molecular diagnostic tests, primarily in oncology, women's health, and mental health. Revenue derives from direct-to-consumer and healthcare-provider diagnostic testing, with limited Medicare/Medicaid reimbursement exposure relative to larger pharma.
Executive Branch ConflictsMYGN held by Trump-administration officials
1 cabinet/senior official reported MYGN positions in OGE Form 278 disclosures across 6 filings.
Donald J. Trump
President · White House
MYRIAD GENETICS INC
Donald J. Trump
President · White House
MYRIAD GENETICS INC
Donald J. Trump
President · White House
MYRIAD GENETICS INC
Donald J. Trump
President · White House
MYRIAD GENETICS INC
Donald J. Trump
President · White House
MYRIAD GENETICS INC
Donald J. Trump
President · White House
MYRIAD GENETICS INC
Lifetime Government AwardsMYGN federal contracts by year
$541K
total awarded · 2005–2005
1
contracts on file
2005
peak year ($541K)
Top contracts by award amount
$541K
Department of Health and Human Serv
2005-09-30
ANALYSIS OF YEAST TWO-HYBRID PROTEINS
1 years · 1 contracts
Smart Money · 13F HoldingsHedge funds holding MYGN
$7.84B
Total MYGN held by tracked 13F funds
4
Funds with MYGN positions
Two Sigma Investments
$5.78B
+40%
2026-03-31
Renaissance Technologies
$2.04B
+20%
2026-03-31
D.E. Shaw & Co.
$21M
holds
2025-12-31
Citadel Advisors
$982K
-70%
2025-12-31
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills to WatchLegislation flagged by our analysis
CMS reimbursement policy updatesFDA diagnostic regulation modernization
Political ProfileWhere MYGN sits in Washington
Myriad has minimal lobbying spend, no documented politician trades, and no named legislative winners/losers. Stock movement driven primarily by clinical trial results, reimbursement decisions, and competitive diagnostics landscape rather than federal policy.
Regulatory ExposureThreats & opportunities
Regulatory threats
- CMS LCD/NCD reimbursement cuts
- FDA oversight of LDTs (Laboratory Developed Tests)
Regulatory opportunities
- CMS coverage expansion for genetic testing
- FDA streamlined approval pathways for companion diagnostics
LobbyingWho's hired to advocate for MYGN
Personalized Medicine CoalitionAmerican Clinical Laboratory Association
Member intelligence layer
Live signals + predictions for MYGN — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades MYGN
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord
Frequently AskedAbout MYGN & political exposure
Does Myriad Genetics, Inc. (MYGN) hold federal contracts?
Yes. Myriad Genetics, Inc. has 1 federal contract awards totaling $540,500, primarily from agencies including Department of Health and Human Services. See full contract list and amounts on this page.
Which Trump cabinet officials own MYGN stock?
1 Trump cabinet members or senior White House staff have disclosed holdings in MYGN on their OGE 278 financial disclosures, including Donald J. Trump. See the Cabinet Conflicts panel for details.
What is MYGN political risk profile?
Government dependence: 25/100. Lobbying intensity: 15/100. Political signal: low.
How does GovGreed track MYGN political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. MYGN data is updated daily from these official federal sources.